Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urologist and radiologist contributions to variation in prostate cancer detection at fusion biopsy.

BJU internationalĀ·2026
Same author

Prophylactic antibiotic in pubertal testicular torsion: Is it Justified?

Journal of pediatric urologyĀ·2026
Same author

Pre-pubertal testicular torsion: A critical analysis of outcomes from a tertiary care center.

Journal of pediatric urologyĀ·2026
Same author

What is lost in an average? Identifying distinct post-radical prostatectomy functional recovery profiles.

BJU internationalĀ·2025
Same author

Pelvic Mass in a Pediatric Patient: AĀ Rare Case of Extraosseous Ewing Sarcoma.

UrologyĀ·2025
Same author

Urinary bother, Urinalysis, and Two-Year Efficacy Follow-Up Results of Phase I Trial of Intravesical Bacillus Calmette-GuƩrin Combined with Intravenous Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder Cancer after Previous Bacillus Calmette-GuƩrin Treatment.

Clinical genitourinary cancerĀ·2024
Same journal

Is Nonpapillary Puncture a Feasible Alternative to Papillary Access in Percutaneous Nephrolithotomy? A Systematic Review and Meta-Analysis.

Journal of endourologyĀ·2026
Same journal

Procedure, Safety, and Outcomes of Patient-Controlled Sedation in Ureteroscopic Lithotripsy: A 7-Year Cohort Study.

Journal of endourologyĀ·2026
Same journal

Clinically Significant Prostate Cancer in Patients Undergoing Holmium Laser Enucleation of Prostate for Benign Hyperplasia: A Preoperative Nomogram and a Postoperative Surveillance Protocol.

Journal of endourologyĀ·2026
Same journal

Bubble Trouble: The Thermal Risk of Ureteral Laser Lithotripsy in an Air Bubble.

Journal of endourologyĀ·2026
Same journal

Development of an Interpretable Machine Learning Model for Predicting Clavien-Dindo Grade ā‰„2 Complications after Unilateral Minimally Invasive Pyeloplasty in UPJO: A Retrospective Cohort Study.

Journal of endourologyĀ·2026
Same journal

Comparison of Appendiceal Onlay Ureteroplasty and Appendiceal Interposition Ureteroplasty for Complex Proximal Ureteral Strictures in Children: Insights Gained from Long-Term Follow-Up.

Journal of endourologyĀ·2026
See all related articles

Related Experiment Video

Updated: Jul 1, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

7.7K

Intermediate-Term Oncologic Outcome Assessment for Robot-Assisted Radical Prostatectomy: Comparing Retzius-Sparing

Ghassan A Barayan1,2, Sami E Majdalany2, Mohit Butaney2

  • 1Department of Surgery, Umm Al-Qura University, Makkah, Saudi Arabia. Henry Ford Hospital, Detroit, Michigan, USA.

Journal of Endourology
|March 2, 2024
PubMed
Summary
This summary is machine-generated.

Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) shows similar intermediate-term oncologic outcomes to standard RARP (S-RARP). Biochemical recurrence rates were comparable between the two surgical approaches in this randomized trial.

Keywords:
Retzius sparingoncologic outcomeprostate cancerroboticrobotic prostatectomy

More Related Videos

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

5.7K
Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction
12:34

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction

Published on: January 3, 2020

16.6K

Related Experiment Videos

Last Updated: Jul 1, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

7.7K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

5.7K
Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction
12:34

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction

Published on: January 3, 2020

16.6K

Area of Science:

  • Urology
  • Oncology
  • Surgical Innovation

Background:

  • Retzius-sparing prostatectomy is increasingly adopted, often linked to improved early continence.
  • However, long-term oncologic outcomes compared to standard techniques remain less understood.
  • This study evaluates intermediate-term oncologic results from a randomized trial.

Purpose of the Study:

  • To compare the intermediate-term oncologic outcomes of Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) versus standard robot-assisted radical prostatectomy (S-RARP).
  • To assess differences in biochemical recurrence (BCR) and survival rates between the two surgical approaches.

Main Methods:

  • A randomized controlled trial comparing RS-RARP and S-RARP in 120 patients.
  • Data collection included baseline, surgical, pathological characteristics, and oncologic outcomes.
  • Median follow-up was approximately 71 months.

Main Results:

  • No significant differences in baseline or surgical characteristics were observed.
  • Higher rates of pathologic T3 disease were noted in the RS-RARP group.
  • No statistically significant difference in positive margin status or biochemical recurrence (BCR) rates was found between groups.
  • Five-year BCR-free survival was 91% for S-RARP and 85% for RS-RARP (p=0.21).

Conclusions:

  • Retzius-sparing and standard robot-assisted radical prostatectomy demonstrate comparable intermediate-term oncologic outcomes.
  • Biochemical recurrence rates were similar between the two techniques.
  • Larger, multi-institutional studies with longer follow-up are needed to confirm these findings.